The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure
暂无分享,去创建一个
[1] W. Balduini,et al. Melatonin, tunneling nanotubes, mesenchymal cells, and tissue regeneration , 2022, Neural regeneration research.
[2] M. Donoso,et al. Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain , 2022, Cells.
[3] T. Kuner,et al. Glioblastoma hijacks neuronal mechanisms for brain invasion , 2022, Cell.
[4] C. Kepley,et al. Identification and Characterization of Tunneling Nanotubes Involved in Human Mast Cell FcεRI-Mediated Apoptosis of Cancer Cells , 2022, Cancers.
[5] V. Uversky,et al. SARS-CoV-2: A Master of Immune Evasion , 2022, Biomedicines.
[6] E. Eugenin,et al. Direct Cell-Cell Communication via Membrane Pores, Gap Junction Channels, and Tunneling Nanotubes: Medical Relevance of Mitochondrial Exchange , 2022, International journal of molecular sciences.
[7] L. Sardo,et al. Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies , 2022, Frontiers in Microbiology.
[8] Sung Hyun Lee,et al. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy , 2022, Frontiers in Oncology.
[9] A. Seguro,et al. Tenofovir-induced renal and bone toxicity: report of two cases and literature review , 2022, Revista do Instituto de Medicina Tropical de Sao Paulo.
[10] W. Wang,et al. Intercellular transfer of mitochondria via tunneling nanotubes protects against cobalt nanoparticle-induced neurotoxicity and mitochondrial damage , 2021, Nanotoxicology.
[11] Ranjeet Kumar,et al. An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy , 2021, Scientific Reports.
[12] J. Garcia,et al. Tunneling nanotube formation promotes survival against 5‐fluorouracil in MCF‐7 breast cancer cells , 2021, FEBS open bio.
[13] M. Levin,et al. Beyond Neurons: Long Distance Communication in Development and Cancer , 2021, Frontiers in Cell and Developmental Biology.
[14] C. Scagnolari,et al. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19 , 2021, Drug Delivery and Translational Research.
[15] E. Eugenin,et al. HIV infection of astrocytes compromises inter-organelle interactions and inositol phosphate metabolism: A potential mechanism of bystander damage and viral reservoir survival , 2021, Progress in Neurobiology.
[16] S. Nath,et al. Amyloid-β induced membrane damage instigates tunneling nanotube-like conduits by p21-activated kinase dependent actin remodulation. , 2021, Biochimica et biophysica acta. Molecular basis of disease.
[17] K. Bhat,et al. Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions , 2021, Scientific Reports.
[18] S. N. Witt,et al. Trojan horses and tunneling nanotubes enable α-synuclein pathology to spread in Parkinson disease , 2021, PLoS biology.
[19] D. Shukla,et al. Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer , 2021, Frontiers in Immunology.
[20] Qiong Zhou,et al. The Functions, Methods, and Mobility of Mitochondrial Transfer Between Cells , 2021, Frontiers in Oncology.
[21] C. Van Lint,et al. Shocking HIV-1 with immunomodulatory latency reversing agents. , 2021, Seminars in immunology.
[22] S. Swindells,et al. The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data? , 2021, Journal of the International Association of Providers of AIDS Care.
[23] B. Malissen,et al. Regulation of Inflammatory Response by Transmembrane Adaptor Protein LST1 , 2021, Frontiers in Immunology.
[24] C. Zurzolo. Tunneling nanotubes: Reshaping connectivity. , 2021, Current opinion in cell biology.
[25] C. Marzolini,et al. Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine , 2021, Clinical Pharmacokinetics.
[26] E. Eugenin,et al. Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell‐to‐cell viral transfer , 2021, Journal of neurochemistry.
[27] J. Moorman,et al. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies , 2021, Cells.
[28] Anice C. Lowen,et al. Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes , 2021, bioRxiv.
[29] E. Haddad,et al. HIV-1 cure strategies: why CRISPR? , 2020, Expert opinion on biological therapy.
[30] M. Donoso,et al. Role of Tunneling Nanotube–like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread , 2020, The Journal of Immunology.
[31] Zhipeng Qiu,et al. Modeling HIV multiple infection. , 2020, Journal of theoretical biology.
[32] D. Wodarz,et al. Quantifying the dynamics of viral recombination during free virus and cell-to-cell transmission in HIV-1 infection , 2020, bioRxiv.
[33] M. Kazanietz,et al. Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease. , 2020, American journal of physiology. Cell physiology.
[34] K. Bhat,et al. Tunneling Nanotubes Mediate Adaptation of Glioblastoma Cells to Temozolomide and Ionizing Radiation Treatment , 2020, iScience.
[35] D. Langford,et al. Inter and Intracellular mitochondrial trafficking in health and disease , 2020, Ageing Research Reviews.
[36] H. Nasser,et al. M-Sec facilitates intercellular transmission of HIV-1 through multiple mechanisms , 2020, Retrovirology.
[37] Zhipeng Qiu,et al. Modeling the role of macrophages in HIV persistence during antiretroviral therapy , 2020, Journal of mathematical biology.
[38] E. Eugenin,et al. HIV infects astrocytes in vivo and egresses from the brain to the periphery , 2020, PLoS pathogens.
[39] B. Julg,et al. Therapeutic Vaccines for the Treatment of HIV. , 2020, Translational research : the journal of laboratory and clinical medicine.
[40] K. Katagiri,et al. HIV Reactivation in Latently Infected Cells with Virological Synapse-Like Cell Contact , 2020, Viruses.
[41] Mirko H. H. Schmidt,et al. Tunneling Nanotubes and Tumor Microtubes in Cancer , 2020, Cancers.
[42] T. Murakami,et al. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus–cell binding , 2020, Proceedings of the National Academy of Sciences.
[43] M. Szeliga,et al. Targeting Glutamine Addiction in Gliomas , 2020, Cancers.
[44] Z. Debyser,et al. Block-And-Lock Strategies to Cure HIV Infection , 2020, Viruses.
[45] C. Van Lint,et al. Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs , 2020, Frontiers in Microbiology.
[46] Eliseo A. Eugenin,et al. Role of cell‐to‐cell communication in cancer: New features, insights, and directions , 2019, Cancer reports.
[47] G. Pilkington,et al. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons , 2019, International journal of molecular sciences.
[48] A. Bosque,et al. HIV-1 Latency and Latency Reversal: Does Subtype Matter? , 2019, Viruses.
[49] R. Ruprecht,et al. Mucosal Antibodies: Defending Epithelial Barriers against HIV-1 Invasion , 2019, Vaccines.
[50] S. Venneti,et al. Glutamine Metabolism in Brain Tumors , 2019, Cancers.
[51] C. Van Lint,et al. Microglial Cells: The Main HIV-1 Reservoir in the Brain , 2019, Front. Cell. Infect. Microbiol..
[52] S. Cherqui,et al. Macrophage polarization impacts tunneling nanotube formation and intercellular organelle trafficking , 2019, Scientific Reports.
[53] M. Clerici,et al. Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance. , 2019, Current opinion in pharmacology.
[54] M. Tolstrup,et al. Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues , 2019, Front. Microbiol..
[55] Xia Wang,et al. HIV low viral load persistence under treatment: Insights from a model of cell-to-cell viral transmission , 2019, Appl. Math. Lett..
[56] H. Gendelman,et al. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice , 2019, Nature Communications.
[57] L. Agosto,et al. Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir. , 2019, Virus research.
[58] E. Masliah,et al. HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein , 2019, Journal of NeuroVirology.
[59] E. Eugenin,et al. HIV infection and latency induce a unique metabolic signature in human macrophages , 2019, Scientific Reports.
[60] M. Kuroda,et al. Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages. , 2019, Cell reports.
[61] Yong-feng Yang,et al. Myosin-X Silencing in the Trabecular Meshwork Suggests a Role for Tunneling Nanotubes in Outflow Regulation , 2019, Investigative ophthalmology & visual science.
[62] C. Flexner,et al. Long-Acting HIV Drugs for Treatment and Prevention. , 2019, Annual review of medicine.
[63] K. Gousset,et al. Correlative cryo-electron microscopy reveals the structure of TNTs in neuronal cells , 2019, Nature Communications.
[64] S. Izadmehr,et al. Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging , 2019, Retrovirology.
[65] E. Freed,et al. Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes , 2018, Journal of Cell Communication and Signaling.
[66] M. Naghavi. "APP"reciating the complexity of HIV-induced neurodegenerative diseases , 2018, PLoS pathogens.
[67] S. Iwami,et al. Dynamics of HIV-1 coinfection in different susceptible target cell populations during cell-free infection. , 2018, Journal of theoretical biology.
[68] V. Piguet,et al. Masters of manipulation: Viral modulation of the immunological synapse , 2018, Cellular microbiology.
[69] Donald W. Harms,et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection , 2018, BMC Immunology.
[70] Subbaya Subramanian,et al. Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer , 2018, Scientific Reports.
[71] M. Bomsel,et al. Live Imaging of HIV-1 Transfer across T Cell Virological Synapse to Epithelial Cells that Promotes Stromal Macrophage Infection. , 2018, Cell reports.
[72] E. Eugenin,et al. The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis , 2018, International journal of molecular sciences.
[73] S. Benichou,et al. Mechanisms for Cell-to-Cell Transmission of HIV-1 , 2018, Front. Immunol..
[74] G. Lugo-Villarino,et al. Tunneling Nanotubes: Intimate Communication between Myeloid Cells , 2018, Front. Immunol..
[75] E. Martegani,et al. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells , 2018, Experimental cell research.
[76] S. Lewin,et al. Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV. , 2018, Cell host & microbe.
[77] E. Eugenin,et al. Tunneling nanotubes (TNT) mediate long-range gap junctional communication: Implications for HIV cell to cell spread , 2017, Scientific Reports.
[78] Teresa M. Ribeiro-Rodrigues,et al. Role of connexin 43 in different forms of intercellular communication – gap junctions, extracellular vesicles and tunnelling nanotubes , 2017, Journal of Cell Science.
[79] E. Boritz,et al. Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. , 2017, Cell reports.
[80] M. D. Den Boer,et al. Tunneling Nanotubes and Gap Junctions–Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions , 2017, Front. Mol. Neurosci..
[81] E. Eugenin,et al. HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim , 2017, Scientific Reports.
[82] K. Manova-Todorova,et al. Imaging Tunneling Membrane Tubes Elucidates Cell Communication in Tumors. , 2017, Trends in cancer.
[83] Beth S. Lee,et al. Regulation of Osteoclast Differentiation by Myosin X , 2017, Scientific Reports.
[84] Y. Iwasa,et al. Number of infection events per cell during HIV-1 cell-free infection , 2017, Scientific Reports.
[85] K. Sahu,et al. Macrophage conditioned medium induced cellular network formation in MCF‐7 cells through enhanced tunneling nanotube formation and tunneling nanotube mediated release of viable cytoplasmic fragments , 2017, Experimental Cell Research.
[86] C. Jorgensen,et al. Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy , 2017, Stem cells international.
[87] M. Tremblay,et al. HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood–Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration , 2017, The Journal of Immunology.
[88] E. Boyden,et al. Influenza virus exploits tunneling nanotubes for cell-to-cell spread , 2017, Scientific Reports.
[89] V. Thayanithy,et al. Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection , 2016, Molecular therapy oncolytics.
[90] M. Colin,et al. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies , 2016, Acta neuropathologica communications.
[91] I. Parker,et al. Communication of Ca(2+) signals via tunneling membrane nanotubes is mediated by transmission of inositol trisphosphate through gap junctions. , 2016, Cell calcium.
[92] R. Dewar,et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.
[93] R. Siliciano,et al. Defective proviruses rapidly accumulate during acute HIV-1 infection , 2016, Nature Medicine.
[94] Hongzhou Lu,et al. The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb , 2016, Scientific Reports.
[95] Andrea K. Thoma-Kress,et al. Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission , 2016, Viruses.
[96] H. Nasser,et al. Potential Role of the Formation of Tunneling Nanotubes in HIV-1 Spread in Macrophages , 2016, The Journal of Immunology.
[97] R. Siliciano,et al. HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.
[98] O. Garaschuk,et al. Brain tumour cells interconnect to a functional and resistant network , 2015, Nature.
[99] M. D. Den Boer,et al. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. , 2015, Blood.
[100] H. Vaudry,et al. Structural and functional analysis of tunneling nanotubes (TnTs) using gCW STED and gconfocal approaches , 2015, Biology of the cell.
[101] Y. Iwasa,et al. Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin , 2015, Scientific Reports.
[102] S. Curley,et al. Radiofrequency treatment alters cancer cell phenotype , 2015, Scientific Reports.
[103] A. Zumbusch,et al. Lipid droplets as a novel cargo of tunnelling nanotubes in endothelial cells , 2015, Scientific Reports.
[104] R. Swanstrom,et al. Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS , 2015, Current HIV/AIDS Reports.
[105] H. Gerdes,et al. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells , 2015, Cell Death and Differentiation.
[106] S. Buchbinder,et al. HIV infection , 2015, Nature Reviews Disease Primers.
[107] J. Kappes,et al. Macrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells , 2014, Cell host & microbe.
[108] R. Siliciano,et al. A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence , 2014, Nature Protocols.
[109] Benjamin K. Chen,et al. Unique Features of HIV-1 Spread through T Cell Virological Synapses , 2014, PLoS pathogens.
[110] V. Thayanithy,et al. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. , 2014, Translational research : the journal of laboratory and clinical medicine.
[111] D. Margolis,et al. Eradicating HIV-1 infection: seeking to clear a persistent pathogen , 2014, Nature Reviews Microbiology.
[112] A. Pau,et al. Antiretroviral therapy: current drugs. , 2014, Infectious disease clinics of North America.
[113] V. Ferreira,et al. Influence of Common Mucosal Co‐Factors on HIV Infection in the Female Genital Tract , 2014, American journal of reproductive immunology.
[114] M. Gerstein,et al. Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body , 2014, PLoS pathogens.
[115] L. Margolis,et al. HIV‐1 Vaginal Transmission: Cell‐Free or Cell‐Associated Virus? , 2014, American journal of reproductive immunology.
[116] K. Manova-Todorova,et al. Tumor exosomes induce tunneling nanotubes in lipid raft-enriched regions of human mesothelioma cells. , 2014, Experimental cell research.
[117] D. Bettenworth,et al. Regulated expression of leukocyte-specific transcript (LST) 1 in human intestinal inflammation , 2014, Inflammation Research.
[118] A. Mak. p53 in cell invasion, podosomes, and invadopodia , 2014, Cell adhesion & migration.
[119] Gerdes,et al. Tunneling nanotubes Diversity in morphology and structure , 2014 .
[120] J. Berman,et al. Cytochrome c dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium‐dependent mechanism , 2013, Journal of neurochemistry.
[121] W. Greene,et al. Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV , 2013, PloS one.
[122] L. Marzo,et al. Myo10 is a key regulator of TNT formation in neuronal cells , 2013, Journal of Cell Science.
[123] R. Siliciano,et al. Targeting HIV latency: pharmacologic strategies toward eradication. , 2013, Drug discovery today.
[124] K. Koyano,et al. Tunneling nanotube formation is essential for the regulation of osteoclastogenesis , 2013, Journal of cellular biochemistry.
[125] E. Verdin,et al. Reactivation of latent HIV by histone deacetylase inhibitors. , 2013, Trends in microbiology.
[126] H. Gerdes,et al. Tunneling nanotubes, an emerging intercellular communication route in development , 2013, Mechanisms of Development.
[127] E. Kremmer,et al. LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation , 2013, Journal of Cell Science.
[128] P. Uchil,et al. Cell-to-Cell Transmission Can Overcome Multiple Donor and Target Cell Barriers Imposed on Cell-Free HIV , 2013, PloS one.
[129] M. Toborek,et al. Infection of human pericytes by HIV-1 disrupts the integrity of the blood–brain barrier , 2012, Journal of cellular and molecular medicine.
[130] R. Siliciano,et al. Redefining the viral reservoirs that prevent HIV-1 eradication. , 2012, Immunity.
[131] Hans-Hermann Gerdes,et al. Long-distance electrical coupling via tunneling nanotubes. , 2012, Biochimica et biophysica acta.
[132] S. Deeks. HIV: Shock and kill , 2012, Nature.
[133] K. Manova-Todorova,et al. Tunneling Nanotubes , 2012, Communicative & integrative biology.
[134] K. Manova-Todorova,et al. Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural Mesothelioma , 2012, PloS one.
[135] Ju Han Kim,et al. Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations , 2012, PloS one.
[136] P. Sharp,et al. Origins of HIV and the AIDS pandemic. , 2011, Cold Spring Harbor perspectives in medicine.
[137] Ron Milo,et al. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy , 2011, Nature.
[138] Davey M. Smith,et al. Tissue-specific HIV-1 infection: why it matters. , 2011, Future virology.
[139] Y. Wang,et al. Tunneling-nanotube development in astrocytes depends on p53 activation , 2011, Cell Death and Differentiation.
[140] K. Williamson,et al. Malaria parasites form filamentous cell-to-cell connections during reproduction in the mosquito midgut , 2011, Cell Research.
[141] Susan Moir,et al. Pathogenic mechanisms of HIV disease. , 2011, Annual review of pathology.
[142] R. Siliciano,et al. HIV latency. , 2011, Cold Spring Harbor perspectives in medicine.
[143] Kevin C. Olivieri,et al. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation , 2012, Retrovirology.
[144] Nickolay V. Bukoreshtliev,et al. Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels , 2010, Proceedings of the National Academy of Sciences.
[145] Alan S. Perelson,et al. Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues , 2010, PLoS Comput. Biol..
[146] O. Schwartz,et al. HIV-1 Virological Synapse: Live Imaging of Transmission , 2010, Viruses.
[147] Q. Sattentau,et al. Cell-to-Cell Spread of Retroviruses , 2010, Viruses.
[148] Marie-Claude Boily,et al. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention , 2010, International journal of epidemiology.
[149] S. Kimura,et al. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex , 2009, Nature Cell Biology.
[150] J. Javitch,et al. Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. , 2009, The American journal of pathology.
[151] E. Hodneland,et al. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells , 2009, FEBS letters.
[152] J. Berman,et al. Tunneling nanotubes (TNT) , 2009 .
[153] Alberto Bosque,et al. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. , 2009, Blood.
[154] J. Berman,et al. Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. , 2009, Cellular immunology.
[155] E. Hodneland,et al. Tunneling nanotube (TNT)-like structures facilitate a constitutive, actomyosin-dependent exchange of endocytic organelles between normal rat kidney cells. , 2008, Experimental cell research.
[156] Nathan M Sherer,et al. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. , 2008, Trends in cell biology.
[157] N. B. Viana,et al. Structure and elastic properties of tunneling nanotubes , 2008, European Biophysics Journal.
[158] H. Gerdes,et al. Tunneling nanotubes: A new route for the exchange of components between animal cells , 2007, FEBS letters.
[159] M. Neil,et al. Structurally Distinct Membrane Nanotubes between Human Macrophages Support Long-Distance Vesicular Traffic or Surfing of Bacteria1 , 2006, The Journal of Immunology.
[160] V. KewalRamani,et al. Dendritic-cell interactions with HIV: infection and viral dissemination , 2006, Nature Reviews Immunology.
[161] Erlend Hodneland,et al. Automated detection of tunneling nanotubes in 3D images , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[162] T. Kornberg,et al. Dependence of Drosophila wing imaginal disc cytonemes on Decapentaplegic , 2005, Nature.
[163] Xiaoling Zhang,et al. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes , 2005, Journal of Cell Science.
[164] Alan S Perelson,et al. HIV dynamics with multiple infections of target cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[165] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[166] J. Berg,et al. A microtubule-binding myosin required for nuclear anchoring and spindle assembly , 2004, Nature.
[167] D. Davis,et al. Cutting Edge: Membrane Nanotubes Connect Immune Cells12 , 2004, The Journal of Immunology.
[168] R. Pomerantz,et al. HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[169] J. Alcamí,et al. Prostratin Induces HIV Activation and Downregulates HIV Receptors in Peripheral Blood Lymphocytes , 2004, Antiviral therapy.
[170] Qingsheng Li,et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[171] Hans-Hermann Gerdes,et al. Nanotubular Highways for Intercellular Organelle Transport , 2004, Science.
[172] Jianbo Chen,et al. Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[173] D. Ho,et al. HIV-1 dynamics in vivo: implications for therapy , 2003, Nature Reviews Microbiology.
[174] J. Zack,et al. Identification of T cell-signaling pathways that stimulate latent HIV in primary cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[175] John P. Moore,et al. Inhibiting sexual transmission of HIV-1 infection , 2003, Nature Reviews Microbiology.
[176] J. Berman,et al. TNF-α Plus IFN-γ Induce Connexin43 Expression and Formation of Gap Junctions Between Human Monocytes/Macrophages That Enhance Physiological Responses 1 , 2003, The Journal of Immunology.
[177] G. Bocharov,et al. Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.
[178] P. Ricciardi-Castagnoli,et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.
[179] Peng Li,et al. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. , 1999, Virology.
[180] D. Richman,et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.
[181] V. Mermall,et al. Unconventional myosins in cell movement, membrane traffic, and signal transduction. , 1998, Science.
[182] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[183] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[184] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[185] Robert F. Siliciano,et al. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency , 1995, Nature Medicine.
[186] R Blumenthal,et al. Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.
[187] R. Strumpf,et al. ACS RX flow support catheter as a temporary stent for dissection or occlusion during balloon angioplasty: initial experience. , 1992, Catheterization and cardiovascular diagnosis.
[188] K Inaba,et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. , 1992, Science.
[189] C. Rinaldo,et al. Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody , 1989, Journal of virology.